Sanders Morris Harris LLC Esperion Therapeutics, Inc. Transaction History

Sanders Morris Harris LLC

  • $585 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 11, 2022
SELL
$4.77 - $6.67 $58,193 - $81,374
-12,200 Reduced 50.0%
12,200 $79,000
Q1 2022

Apr 11, 2022
BUY
$3.34 - $5.56 $40,748 - $67,832
12,200 Added 100.0%
24,400 $113,000
Q4 2020

Jan 26, 2021
BUY
$24.2 - $35.76 $295,240 - $436,272
12,200 New
12,200 $328,000

Others Institutions Holding ESPR

# of Institutions
208
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $160M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Sanders Morris Harris LLC Portfolio

Follow Sanders Morris Harris LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanders Morris Harris LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sanders Morris Harris LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email